Facioscapulohumeral Muscular Dystrophy (FSHD) Pipeline Globally, several prominent pharma companies are actively working on developing therapies for Facioscapulohumeral Muscular Dystrophy. The launch of the emerging therapies is expected to improve the treatment scenario in the coming years. Currently, there are no specific therapeutic cures for Facioscapulohumeral Muscular Dystrophy (FSHD). But in 2010, the standard of care […]
